Stock To Watch: Novartis AG (NYSE:NVS)


The leading market experts have placed a mean price target of $93.2500 on Novartis AG (NYSE:NVS) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $1.1600 a share for the upcoming quarter and $4.7300 for the current fiscal. Technical View The technical analysis of Novartis AG Common Stock plainly substantiates that the 50-day moving average of Novartis AG Common Stock is $80.9134, and stock is hovering 1.7520 or +2.1653% distant from $80.9134. It is noted that the 200-day MA is $76.9796, and Novartis AG Common Stock stock is $5.6858 or +7.3861% off from this point. Novartis AG (NYSE:NVS) 52-week high is $104.2800 and the 52-week low is $69.9000. This explains if the stock moves $-21.6146, it will post a 52-week high. In event of $+18.2624% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Novartis AG Common Stock, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Novartis AG (NYSE:NVS) ratio came in at 29.5128. The stock last ended the trading session at $82.6654 and registered a market cap of $196.84B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Novartis AG (NYSE:NVS) PEG ratio is at 2.8500.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 19 times, 1 visits today)